NEW YORK, NY – November 01, 2023 – LifeMD, Inc. is the current YTD leader in the PRISM Emerging Healthcare Index. The company has seen a ~226% increase this year and is trading at approximately $6 per share. This price falls on the higher end of its 52-week range of $1.14 – $7.40 which may indicate the potential for continued growth in a potentially shorter time frame. The company’s market cap is $227MM with a 3-month average trading volume of 500K shares.
The Healthcare index YTD leader LifeMD, is a telehealth and wellness company that focuses on providing a range of health and wellness services to individuals. They offer virtual medical consultations, prescription medications, and various wellness programs, with a primary emphasis on optimizing health and well-being. LifeMD’s services are designed to be accessible to a wide range of individuals, allowing them to address their healthcare needs and make informed decisions about their overall wellness.
LifeMD recently performed a joint study with Particle Health, an intelligent data platform that aggregates and delivers actionable patient data and insights to healthcare companies. The research study allowed the Particle platform to compliantly review health histories collected from electronic healthcare records provided by Life MD. This process save healthcare providers valuable time by streamlining the patient weight management journey to determine eligibility for treatment with Glucagon-Like Peptide-1 (GLP-1) drugs, allowing doctors the ability to make more efficient and informed decisions. The company intends to announce its third quarter earnings after market close on November 8th that will be followed by a conference call.
Visit PRISM MarketView to discover more emerging indices and stay up to date on micro/small cap news.
About PRISM MarketView:
Established in 2020, PRISM MarketView is dedicated to the monitoring and analysis of small cap stocks in burgeoning sectors. We deliver up-to-the-minute financial market news, provide comprehensive investor tools and foster a dynamic investor community. Central to our offerings are proprietary indexes that observe emerging sectors, including biotech, clean energy, next-generation tech, medical devices and beyond. Visit us at prismmarketview.com and follow us on Twitter.
PRISM MarketView does not provide investment advice.
(by Ashlee Vogenthaler)